PDGFRA and cancer: Here, we observed an increase in LOH (immune escape), CNV burden enrichment, TMB and TNB values in most of the cancer types with the CN gain of PDGFRA pathway, except in ACC and UCEC, suggesting a new research direction for ACC and UCEC.